These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37360469)
1. Synthesis and Fluorescence Properties of 4-Cyano and 4-Formyl Melatonin as Putative Melatoninergic Ligands. Bartolucci S; Retini M; Fanini F; Paderni D; Piersanti G ACS Omega; 2023 Jun; 8(24):22190-22194. PubMed ID: 37360469 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II. Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands. Attia MI; Witt-Enderby PA; Julius J Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles. Tsotinis A; Afroudakis PA; Davidson K; Prashar A; Sugden D J Med Chem; 2007 Dec; 50(25):6436-40. PubMed ID: 17988084 [TBL] [Abstract][Full Text] [Related]
5. In search of novel and therapeutically significant melatoninergic ligands. Mody SM; Hu Y; Ho MK; Wong YH Recent Pat CNS Drug Discov; 2007 Nov; 2(3):241-5. PubMed ID: 18221235 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of benzocycloalkane derivatives as new conformationally restricted ligands for melatonin receptors. Kloubert S; Mathé-Allainmat M; Andrieux J; Sicsic S; Langlois M Bioorg Med Chem Lett; 1998 Dec; 8(23):3325-30. PubMed ID: 9873728 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3). Leclerc V; Yous S; Delagrange P; Boutin JA; Renard P; Lesieur D J Med Chem; 2002 Apr; 45(9):1853-9. PubMed ID: 11960497 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands. Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848 [TBL] [Abstract][Full Text] [Related]
9. Indole-based melatonin analogues: Synthetic approaches and biological activity. Wang SY; Shi XC; Laborda P Eur J Med Chem; 2020 Jan; 185():111847. PubMed ID: 31727472 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of new melatoninergic hexahydroindenopyridines. Moreno L; Berenguer I; Diaz A; Marín P; Párraga J; Caignard DH; Figadère B; Cabedo N; Cortes D Bioorg Med Chem Lett; 2014 Aug; 24(15):3534-6. PubMed ID: 24930835 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands. Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation. Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands. Sun LQ; Chen J; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C Bioorg Med Chem Lett; 2004 Mar; 14(5):1197-200. PubMed ID: 14980664 [TBL] [Abstract][Full Text] [Related]